The effects of thiazolidinediones on human bone marrow stromal cell differentiation in vitro and in thiazolidinedione-treated patients with type 2 diabetes

An Antidiabetic Thiazolidinedione Is a High Affinity Ligand for Peroxisome Proliferator-activated Receptor γ (PPARγ)

Jürgen M. Lehmann, Linda B. Moore, Tracey Smith-Oliver et al. · Journal of Biological Chemistry · 1995 · 3.6K citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial

The Lancet · 2006 · 1.7K citations

Medicine, Endocrinology, Internal Medicine +12

Preservation of Pancreatic β-Cell Function and Prevention of Type 2 Diabetes by Pharmacological Treatment of Insulin Resistance in High-Risk Hispanic Women

Thomas A. Buchanan, Anny H. Xiang, Ruth Peters et al. · Diabetes · 2002 · 1.3K citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17

Improvement in Glucose Tolerance and Insulin Resistance in Obese Subjects Treated with Troglitazone

John J. Nolan, Bernhard Ludvik, P. Beerdsen et al. · New England Journal of Medicine · 1994 · 935 citations · Full text

Medicine, Endocrinology, Pharmacology +15

Evidence for an inverse relationship between the differentiation of adipocytic and osteogenic cells in rat marrow stromal cell cultures

J.N. Beresford, J. Bennett, C. Devlin et al. · Journal of Cell Science · 1992 · 848 citations

Life Sciences, Biochemistry, Cell Biology +17